Analyze Diet

Effects of polymyxin B and Salmonella typhimurium antiserum on horses given endotoxin intravenously.

Abstract: Polymyxin B and an antiserum against an Re mutant Salmonella typhimurium were evaluated for protective effect in an equine model endotoxemia. Six 3- to 5-month-old foals were given endotoxin (0.25 micrograms/kg of body weight) IV after no pretreatment, or pretreatment with polymyxin B (6,000 U/kg, IV) or S typhimurium antiserum (1.5 ml/kg, IV). When given without pretreatment, endotoxin caused transient recumbency and increases in rectal temperature, and heart and respiratory rates. In addition, leukopenia and increases in circulating tumor necrosis factor (TNF) and interleukin 6 (IL-6) activities were detected. Compared with results obtained when endotoxin was given alone, pretreatment with polymyxin B resulted in significantly (P < 0.05) lower maximal plasma TNF and IL-6 activities, and significantly lower rectal temperature and respiratory rate. In contrast, compared with effects of endotoxin given without pretreatment, use of antiserum was associated with significantly (P < 0.05) higher respiratory rate, maximal plasma IL-6 activity, and total TNF response (as determined by areas under curves of plasma TNF vs time). These results indicate that polymyxin B may have potential as a treatment for equine endotoxemia. Salmonella typhimurium antiserum had no positive effect in this model, and, under certain conditions, may exacerbate the actions of endotoxin.
Publication Date: 1994-07-01 PubMed ID: 7978630
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research tested the potential protective effects of polymyxin B and an antiserum against Salmonella typhimurium in horses injected with endotoxin, a harmful substance. The results suggested that polymyxin B may be beneficial in treating endotoxemia in horses, while the antiserum showed no positive effect and may even make the endotoxin effects worse under certain conditions.

Research Methodology

  • This study utilized a sample of six foals aged between three to five months to evaluate the potential protective effects of polymyxin B and Salmonella typhimurium antiserum against injected endotoxins.
  • The researchers administrated endotoxins into the foals intravenously, at a dosage of 0.25 micrograms per kilogram of body weight, either without any pretreatment or preceded by pretreatment with either polymyxin B at a dose of 6000 units per kilogram, or Salmonella typhimurium antiserum at a dose of 1.5 milliliters per kilogram.

Findings

  • Endotoxins administration without pretreatment resulted in transient recumbency, increased rectal temperature, and accelerated heart and respiratory rates. It also led to leukopenia and a rise in tumor necrosis factor (TNF) and interleukin 6 (IL-6).
  • Pre-treatment with polymyxin B resulted in significantly lower increases in plasma TNF and IL-6 activities, rectal temperature, and respiratory rate compared to when endotoxin was administered alone.
  • Use of the Salmonella typhimurium antiserum, on the other hand, resulted in a significant increase in the respiratory rate, maximal plasma IL-6 activity, and total TNF response compared to when endotoxin was given without pretreatment.

Conclusions

  • Polymyxin B shows promise as a potential treatment for endotoxemia in horses, due to it substantially alleviating the adverse effects of endotoxin.
  • In contrast, the Salmonella typhimurium antiserum was found to not only have no positive effects on mitigating the impact of endotoxin but may also exacerbate the endotoxin’s detrimental effects under certain conditions.

Cite This Article

APA
Durando MM, MacKay RJ, Linda S, Skelley LA. (1994). Effects of polymyxin B and Salmonella typhimurium antiserum on horses given endotoxin intravenously. Am J Vet Res, 55(7), 921-927.

Publication

ISSN: 0002-9645
NlmUniqueID: 0375011
Country: United States
Language: English
Volume: 55
Issue: 7
Pages: 921-927

Researcher Affiliations

Durando, M M
  • Department of Large Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, Gainesville 32610.
MacKay, R J
    Linda, S
      Skelley, L A

        MeSH Terms

        • Animals
        • Body Temperature / drug effects
        • Endotoxins / toxicity
        • Escherichia coli
        • Heart Rate / drug effects
        • Horses
        • Immunization, Passive
        • Interleukin-6 / blood
        • Leukocyte Count / drug effects
        • Lipopolysaccharides / toxicity
        • Polymyxin B / therapeutic use
        • Respiration / drug effects
        • Salmonella typhimurium / immunology
        • Toxemia / blood
        • Toxemia / immunology
        • Toxemia / prevention & control
        • Tumor Necrosis Factor-alpha / analysis

        Citations

        This article has been cited 8 times.
        1. van Spijk JN, Beckmann K, Wehrli Eser M, Stirn M, Steuer AE, Saleh L, Schoster A. Preliminary Investigation of Side Effects of Polymyxin B Administration in Hospitalized Horses. Antibiotics (Basel) 2023 May 5;12(5).
          doi: 10.3390/antibiotics12050854pubmed: 37237756google scholar: lookup
        2. van Spijk JN, Beckmann K, Wehrli Eser M, Boxler M, Stirn M, Rhyner T, Kaelin D, Saleh L, Schoster A. Adverse effects of polymyxin B administration to healthy horses. J Vet Intern Med 2022 Jul;36(4):1525-1534.
          doi: 10.1111/jvim.16470pubmed: 35801274google scholar: lookup
        3. Oliver-Espinosa O. Foal Diarrhea: Established and Postulated Causes, Prevention, Diagnostics, and Treatments. Vet Clin North Am Equine Pract 2018 Apr;34(1):55-68.
          doi: 10.1016/j.cveq.2017.11.003pubmed: 29395727google scholar: lookup
        4. David SA. Antimicrobial peptides for gram-negative sepsis: a case for the polymyxins. Front Immunol 2012;3:252.
          doi: 10.3389/fimmu.2012.00252pubmed: 22912638google scholar: lookup
        5. Nguyen TB, Adisechan AK, Suresh Kumar EV, Balakrishna R, Kimbrell MR, Miller KA, Datta A, David SA. Protection from endotoxic shock by EVK-203, a novel alkylpolyamine sequestrant of lipopolysaccharide. Bioorg Med Chem 2007 Sep 1;15(17):5694-709.
          doi: 10.1016/j.bmc.2007.06.015pubmed: 17583517google scholar: lookup
        6. Sil D, Shrestha A, Kimbrell MR, Nguyen TB, Adisechan AK, Balakrishna R, Abbo BG, Malladi S, Miller KA, Short S, Cromer JR, Arora S, Datta A, David SA. Bound to shock: protection from lethal endotoxemic shock by a novel, nontoxic, alkylpolyamine lipopolysaccharide sequestrant. Antimicrob Agents Chemother 2007 Aug;51(8):2811-9.
          doi: 10.1128/AAC.00200-07pubmed: 17548488google scholar: lookup
        7. Magdesian KG. Neonatal foal diarrhea. Vet Clin North Am Equine Pract 2005 Aug;21(2):295-312, vi.
          doi: 10.1016/j.cveq.2005.04.009pubmed: 16051051google scholar: lookup
        8. Hubert JD, Seahorn TL, Klei TR, Hosgood G, Horohov DW, Moore RM. Clinical signs and hematologic, cytokine, and plasma nitric oxide alterations in response to Strongylus vulgaris infection in helminth-naïve ponies. Can J Vet Res 2004 Jul;68(3):193-200.
          pubmed: 15352544